Amgen’s Blincyto (blinatumomab) has been recommended by the National Institute for Health and Care Excellence (NICE) to treat ...

The phase 3 SERENA-6 study randomised patients with HR-positive, HER2-negative advanced breast cancer whose tumours had an ...

Johnson & Johnson (J&J) has shared positive results from a late-stage study evaluating a subcutaneous (SC) version of Tremfya ...

NHS England has announced that it has appointed Sir James Mackey as its new chief executive officer (CEO), following Amanda ...

At Precision Medicine Group (PMG), DEI is a key consideration across the drug development process, especially when it comes to patient engagement in clinical trials. We start with insights and a firm ...

The US Food and Drug Administration (FDA) has approved Mirum Pharmaceuticals’ Ctexli (chenodiol) to treat adults with ...

The National Institute of Health and Care Excellence (NICE) has recommended pharmaand’s (pharma&) Rubraca (rucaparib) as a ...

Recce Pharmaceuticals has shared positive data from a mid-stage study of its RECCE 327 topical gel (R327G) in acute bacterial ...

Global healthcare communications company Porterhouse Medical has announced the appointment of Michael Tague as president of ...

In 1958, in his book Nation of Immigrants, John F Kennedy mused: ‘One of America’s characteristics has always been the lack ...

Coming in first on the list of Top 25 Pharma Companies US Rx is AbbVie, reaching $41,857m in US Rx revenue in 2023 and ...

Gilead Sciences’ seladelpar has been granted conditional marketing authorisation by the European Commission (EC) to treat ...